Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersSurgical Critical Care Physician in Colorado Springs, CO
NPI: 1043266463Primary Practice Location
UCH-MEMORIAL HEALTH SYSTEM
1400 E Boulder St, Colorado Springs, CO
Primary Employer
UCHealth Medical Group
uchealth.org
HQ Phone
Get M.D. Thomas's Phone Numberphone_androidMobile
Get M.D. Thomas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 24 | 31 |
| 2 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 23 | 23 |
| 3 | 99231Subsequent hospital inpatient care, typically 15 minutes per day | 11 | 13 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 11 | 11 |
Authors: Moskowitz, Eliza, Schroeppel, Thomas
Journal: Trauma Surg Acute Care Open
Publication Date: 2018-02-20
Validation of the American Association for the Surgery of Trauma Emergency General Surgery Grading System for Colorectal Resection: An EAST Multicenter Study.
Authors: Daniel Yeh, Brittany Aicher, Sahil Gambhir, Brandon Bruns, Jordan Estroff, Linda Dultz, Martin Zielinski, Nikolay Bugaev, Jeffry Nahmias, Michael Truitt, Jose Diaz, Daniel Grabo, Cheralyn Hendrix, Ursula Simonoski, Catherine Velopulos, Gregory Peck, Maryanne Howard, Daniel Cullinane, Alejandro Betancourt-Ramirez
Propofol Infusion Syndrome: Efficacy of a Prospective Screening Protocol.
Authors: Martin Croce
Journal: Am Surg
Lead Sponsor: Atox Bio Ltd
Intervention / Treatment: DRUG: Placebo, DRUG: Reltecimod 0.5 mg/kg
Lead Sponsor: InVivo Therapeutics
Intervention / Treatment: DEVICE: Neuro-Spinal Scaffold
Lead Sponsor: Atox Bio Ltd
Collaborators: Biomedical Advanced Research and Development Authority
Intervention / Treatment: DRUG: AB103 0.5 mg/kg, OTHER: NaCl 0.9%
